Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Q3 2025 vs. Q2 2025
How the institutions holding Aspire Biopharma Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 16 | 25 | +9 |
| Shares | 2.04M | 3.12M | +1.08M (+52.8%) |
| Value | $544.7K | $645.6K | +$100.9K (+18.5%) |
New holders (12)
Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 428,552 | $88.3K | 0.00% |
| Geode Capital Management, LLC | 250,161 | $51.5K | 0.00% |
| Antara Capital LP | 202,897 | $41.8K | 8.53% |
| Resolute Partners Group | 82,783 | $17.1K | 0.00% |
| P Schoenfeld Asset Management LP | 58,563 | $12.1K | 0.00% |
| Avion Wealth | 54,113 | $11.0K | 0.00% |
| Crossingbridge Advisors, LLC | 24,348 | $7.42K | 0.00% |
| Tower Research Capital LLC (TRC) | 31,120 | $6.41K | 0.00% |
| XTX Topco Ltd | 27,851 | $5.74K | 0.00% |
| Colony Group, LLC | 12,538 | $2.58K | 0.00% |
| UBS Group AG | 7,661 | $1.58K | 0.00% |
| SOA Wealth Advisors, LLC. | 2,920 | $602 | 0.00% |
Sold out (3)
Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 18,701 | $5.03K |
| Scientech Research LLC | 16,514 | $4.44K |
| Raymond James Financial Inc | 2,500 | $673 |